Thin-cap fibroatheroma
1 paper
Trial sponsors
Company1 trialPhase 424 people
1 trialPhase 42,190 people
Latest
2 in 12 monthsAtherosclerosis
Discordant fatty acid profile drives residual inflammatory risk in metabolically vulnerable patients with low atherogenic lipoprotein burden
Cohort study of 263,481 peopleBiomarkers